Expertise in
3
conditions

Takao Tamura

Ikoma, JP 
Expertise in
3
conditions
Ikoma, JP 

Overview

Takao Tamura practices practicing medicine in Ikoma, Japan.

Mr. Tamura is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Colorectal Cancer, Gastroesophageal Junction Cancer, Esophageal Cancer, and Pancreaticoduodenectomy.

He is actively involved in clinical research, co-authoring 54 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Ikoma, 6300293, Japan
Other Locations
Nara-shi, Japan
Osaka, 5890014, Japan
Sayama, Japan
Shikoku Chuo, Japan
Higashi-osaka, Japan
Sayama, Japan
Kobe, 6500017, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
Enrollment Status: Completed
Publish Date: June 09, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3

54 Total Publications

Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
Journal: International journal of clinical oncology
Published: June 24, 2025

Frequently Asked Questions about Takao Tamura

Is Takao Tamura a top-rated expert for Stomach Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Takao Tamura is classified as an Advanced expert for Stomach Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Takao Tamura participate in research or clinical trials?

Yes. Takao Tamura has published 54 articles and abstracts on conditions like Stomach Cancer. You can view a list of Takao Tamura's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tamura's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile